VT2025 On-Demand
We are pleased to offer complimentary access to the On-Demand Archive of each Session from the 20th Annual International Symposium on Ventricular Arrhythmias, held in Philadelphia on October 10-11, 2025.
Day 1
|
Welcome and Introductions |
|
SESSION I |
|
CT vs MRI for Definition of Scar Substrates and Emerging Role of Photon Counting CT |
|
Non-invasive Assessment of the Ventricular Arrhythmogenic Substrate: ECGi in Combination with CMR |
|
Near Field Analysis and ADAS Software to Localize Potential Ablation Sites |
|
Image Based Dissection of Ventricular Tachycardia Circuitry: Bridging the Gap Between Structure and Electrical Activity |
|
Panel Discussion with Q&A Session |
|
RCT – in EuroHeart – Study Results and Potential Implications |
|
SESSION II |
|
Device Prevention of SCD: Where Are We in 2025 |
|
New ICD Systems for Treating VT Without Intravascular Leads |
|
Clinical Value in Visualization of the Conduction System for CRT |
|
Left Bundle Pacing and Optimized CRT with Novel ICD Leads |
|
Can Quantitative Vector Screening for SubQ ICD Reduce Inappropriate Shocks? |
|
EP Heavyweight Debate |
|
Panel Discussion with Q&A Session |
|
SESSION III |
|
AI Assisted ECG as a Risk Prediction Tool for VF |
|
Updates on the His-Purkinje System in VF |
|
Multicenter Study of Idiopathic VF: Detection of Etiological Diagnosis (hidden diseases) by Long Term Monitoring |
|
Distinguishing Pseudo Torsades de Pointes from True Torsades de Pointes |
|
Prerecorded Case of VF Ablation – Bordeaux Strategy |
|
BRAVE Study and Brugada Syndrome: Clinical Implications |
|
Panel Discussion with Q&A Session |
|
SESSION IV Hospital of University of Pennsylvania, Philadelphia, PA Operators/Onsite discussants:
|
|
SESSION V |
|
How Connexin and Ion Channel Alterations Combine to Build the Functional Part of the VT Substrate |
|
Detailed Substrate Distribution and Outcome after Catheter Ablation in Gene Positive and Gene Elusive Patients with NICM |
|
Overcoming the Arrhythmia Management Challenges Posed by Myocardial Inflammation |
|
Desmosomal Ultrastructure to Identify Novel Molecular Targets for VT Ablation |
|
Panel Discussion with Q&A Session |
|
SESSION VI |
|
Results from the LESS VT Study in NICM |
|
Brazilian BiV versus CSP RCT |
| Late Breaking Clinical Trial Competition |
|
A Dual-Energy Lattice-Tip Focal Catheter for Mapping and Ablation to Treat Ventricular Tachycardia: Acute Outcomes of the Sphere-9 VT Early Feasibility Study |
|
Ultralow Temperature Cryoablation of Ventricular Tachycardia: Interim Analysis of Acute Outcomes of the FULCRUM-VT Trial |
|
High-Voltage Focal Pulsed Field Ablation to Treat Scar-Related Ventricular Tachycardia: Final 6-Month Outcomes of the First-in-Human VCAS Trial |
|
Panel Discussion |
|
New/Ongoing Trials – Rapid Fire Presentations |
|
Radiate VT Update |
| FACILE VT Roderick Tung, MD |
| EASY-R: Outcomes with a Novel Pericardial Access Tool Vivek Reddy, MD |
| Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT Douglas Packer, MD |
| Words of Advice – Are we Heading in the Right Direction? David Callans, MD |
|
SESSION VII |
|
The Misleading QRS: Discrepancies Between VT Morphology and Site of Origin |
|
ARVC VT Endo Only Ablation: Who Benefits/Targeting ICE Defined Aneurysms for Better Outcome |
|
Progress in Mapping Fixed Versus Functional Block in VT Substrate Ablation |
|
Cardiogenetic Disease: Role of the Immune System |
|
Pacemapping for VT Ablation: New Insights |
|
Presence of Mid-Myocardial Fibrosis in Ventricular Endocardial Electrograms is Related to Power of Patient-Specific Frequency Bands |
|
PFA for Bailout VT Ablation in USA – Early Clinical Experience + Some Challenges to Overcome |
|
Panel Discussion with Q&A Session |
Francis Marchlinski, MD
Andre d’Avila, MD, PhD
David Callans, MD
Srinivas Dukkipati, MD
Vivek Reddy, MD
